Edition:
United States

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

1.59USD
4:00pm EDT
Change (% chg)

-- (+0.00%)
Prev Close
$1.59
Open
$1.60
Day's High
$1.60
Day's Low
$1.56
Volume
39,500
Avg. Vol
103,643
52-wk High
$3.27
52-wk Low
$1.25

CRIS.OQ

Chart for CRIS.OQ

About

Curis, Inc. is a biotechnology company. The Company is engaged in the development and commercialization of drug candidates for the treatment of human cancers. The Company's drug candidate, CUDC-907, is an orally available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes.... (more)

Overall

Beta: 1.72
Market Cap(Mil.): $205.40
Shares Outstanding(Mil.): 129.18
Dividend: --
Yield (%): --

Financials

  CRIS.OQ Industry Sector
P/E (TTM): -- 39.80 37.05
EPS (TTM): -0.28 -- --
ROI: -39.98 -5.86 14.35
ROE: -50.95 -4.70 15.56

BRIEF-Curis reports Q1 loss of $0.07 per share

* Q1 earnings per share view $-0.08 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

May 09 2016

BRIEF-Curis Inc names new CFO

* Appointment of James E. Dentzer as chief financial and chief administrative officer

Mar 30 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.